ACXP

Acurx Pharmaceuticals (ACXP)

Acurx Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACXP

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/05/02	20:00	PR Newswire (US)	Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/04/25	23:12	PR Newswire (US)	Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/04/23	23:57	PR Newswire (US)	Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/03/19	20:33	IH Market News	Unilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and More	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/03/18	20:12	IH Market News	Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/03/18	20:01	PR Newswire (US)	Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/03/04	21:01	PR Newswire (US)	Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/02/27	21:01	PR Newswire (US)	Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/02/23	23:30	GlobeNewswire Inc.	New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/02/16	23:30	GlobeNewswire Inc.	New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/02/02	23:30	GlobeNewswire Inc.	New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/02/01	23:33	GlobeNewswire Inc.	New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/01/29	21:00	PR Newswire (US)	Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/01/27	00:55	GlobeNewswire Inc.	New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/01/23	21:01	PR Newswire (US)	Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/01/22	20:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/01/19	23:30	GlobeNewswire Inc.	New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/01/17	21:01	PR Newswire (US)	Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/01/05	23:30	GlobeNewswire Inc.	New to The Street Announces its Four Corporate Interviews, Episode 543, Airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2024/01/03	22:00	PR Newswire (US)	Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/12/11	21:01	PR Newswire (US)	Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/12/08	23:46	GlobeNewswire Inc.	New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/12/07	23:20	GlobeNewswire Inc.	New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/12/01	23:30	GlobeNewswire Inc.	New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/11/24	23:30	GlobeNewswire Inc.	New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/11/17	23:30	GlobeNewswire Inc.	New to The Street Announces Episode 530 with Six Corporate Interviews, Airing on the Fox Business Network, Monday, November 20, 2023, at 10:30 PM PT	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/11/16	07:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/11/16	06:49	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ACXP	Acurx Pharmaceuticals Inc
2023/11/14	21:01	PR Newswire (US)	Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update	NASDAQ:ACXP	Acurx Pharmaceuticals Inc